期刊文献+

Weichang'an and 5-fluorouracil suppresses colorectal cancer in a mouse model 被引量:5

Weichang'an and 5-fluorouracil suppresses colorectal cancer in a mouse model
下载PDF
导出
摘要 AIM: To examine the effect of Weichang'an(WCA) and 5-fluorouracil(5-Fu) on colorectal tumor and hepatic metastasis in a mouse model. METHODS: Quantitative determination of hesperidin, the effective component in WCA decoction, was performed using Hp LC. In vitro cytotoxicity of WCA was determined by treating HCT-116 cells with WCA diluents or serum extracted from rats that received WCA by oral gavage for 1 wk and MTT assays. Forty-eight nude mice received cecum implantation with tumor blocks subcutaneously amplified from human colon cancer cell line HCT-116. Mice were randomly divided into four treatment groups: control(CON), WCA, 5-Fu and combination(WCA + 5-Fu). pathological examination of tumors consisted of tissue sectioning and hematoxylin and eosin staining. Tumor weight and size were measured, and the number of metastatic l e s i o n s wa s c o u n t e d. S e r u m c a r c i n o e m b r yo n i c antigen(CEA) level was determined by ELISA. The expression levels of tumor genesis and metastasisrelated proteins β-catenin and matrix metalloproteinase(MMp)-7 were measured by real-time quantitative reverse transcriptase polymerase chain reaction(RTp CR), immunohistochemistry and immunoblotting. Cell fractionation was used to investigate intracellular distribution of β-catenin.RESULTS: parenchymal tumors were palpable in the abdomens of nude mice 2 wk post-implantation and orthotopic tumor formation rate was 100% in all groups. 5-Fu treatment alone significantly decreased tumor weight compared to the CON group(1.203 ± 0.284 g vs 1.804 ± 0.649 g, p < 0.01). WCA treatment alone reduced the rate of metastasis(50% vs 100%,p < 0.05). Combination treatment of WCA + 5-Fu was the most effective, reducing the tumor weight(1.140 ± 0.464 g vs 1.804 ± 0.649 g, p < 0.01) and size(1493.438 ± 740.906 mm3 vs 2180.259 ± 816.556 mm3, p < 0.05), the rate of metastases(40% vs 100%, p < 0.01), and serum CEA levels(31.263 ± 7.421 μg/L vs 43.040 ± 11.273 μg/L, p < 0.05). Expression of β-catenin and MMp-7 was decreased in drug-treated groups compared to controls, as detected using realtime quantitative RT-p CR, immunohistochemistry and immunoblotting, respectively. Cell fractionation assays revealed that nuclear translocation of β-catenin was reduced by WCA and/or 5-Fu treatments. CONCLUSION: Combination of WCA with 5-Fu significantly inhibited colon tumor growth and hepatic metastases. Decreased expression of β-catenin and MMp-7 may be important. AIM: To examine the effect of Weichang’an(WCA) and 5-fluorouracil(5-Fu) on colorectal tumor and hepatic metastasis in a mouse model. METHODS: Quantitative determination of hesperidin, the effective component in WCA decoction, was performed using Hp LC. In vitro cytotoxicity of WCA was determined by treating HCT-116 cells with WCA diluents or serum extracted from rats that received WCA by oral gavage for 1 wk and MTT assays. Forty-eight nude mice received cecum implantation with tumor blocks subcutaneously amplified from human colon cancer cell line HCT-116. Mice were randomly divided into four treatment groups: control(CON), WCA, 5-Fu and combination(WCA + 5-Fu). pathological examination of tumors consisted of tissue sectioning and hematoxylin and eosin staining. Tumor weight and size were measured, and the number of metastatic l e s i o n s wa s c o u n t e d. S e r u m c a r c i n o e m b r yo n i c antigen(CEA) level was determined by ELISA. The expression levels of tumor genesis and metastasisrelated proteins β-catenin and matrix metalloproteinase(MMp)-7 were measured by real-time quantitative reverse transcriptase polymerase chain reaction(RTp CR), immunohistochemistry and immunoblotting. Cell fractionation was used to investigate intracellular distribution of β-catenin.RESULTS: parenchymal tumors were palpable in the abdomens of nude mice 2 wk post-implantation and orthotopic tumor formation rate was 100% in all groups. 5-Fu treatment alone significantly decreased tumor weight compared to the CON group(1.203 ± 0.284 g vs 1.804 ± 0.649 g, p < 0.01). WCA treatment alone reduced the rate of metastasis(50% vs 100%,p < 0.05). Combination treatment of WCA + 5-Fu was the most effective, reducing the tumor weight(1.140 ± 0.464 g vs 1.804 ± 0.649 g, p < 0.01) and size(1493.438 ± 740.906 mm3 vs 2180.259 ± 816.556 mm3, p < 0.05), the rate of metastases(40% vs 100%, p < 0.01), and serum CEA levels(31.263 ± 7.421 μg/L vs 43.040 ± 11.273 μg/L, p < 0.05). Expression of β-catenin and MMp-7 was decreased in drug-treated groups compared to controls, as detected using realtime quantitative RT-p CR, immunohistochemistry and immunoblotting, respectively. Cell fractionation assays revealed that nuclear translocation of β-catenin was reduced by WCA and/or 5-Fu treatments. CONCLUSION: Combination of WCA with 5-Fu significantly inhibited colon tumor growth and hepatic metastases. Decreased expression of β-catenin and MMp-7 may be important.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第4期1125-1139,共15页 世界胃肠病学杂志(英文版)
基金 Supported by Natural Science Research Fund of Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Budgetary Scientific Research Project of the Education Commission of Shanghai"The impact of Weichang’an decoction onβ-catenin/MMP7 signaling pathway in nude mice with hepatic metastasis from colorectal cancer:a study on the molecular mechanism",No.2011JW33 Young Talent Scientific Research Project of Shanghai Municipal Commission of Health and Family Planning"Efficacy Evaluation of combined therapy with TCM and western medicine for the treatment of hepatic metastasis from unresectable colorectal cancer",No.20134y141
关键词 COLORECTAL cancer HEPATIC METASTASIS Weichang’an f Colorectal cancer Hepatic metastasis Weichang’an f
  • 相关文献

参考文献20

  • 1Selvaraj Aranganathan,Namasivayam Nalini.Antiproliferative Efficacy of Hesperetin (Citrus Flavanoid) in 1,2‐Dimethylhydrazine‐Induced Colon Cancer[J]. Phytother. Res. . 2013 (7)
  • 2Yan Xu,Ai Guang Zhao,Zhao Yan Li,Gang Zhao,Yong Cai,Xiao Hong Zhu,Ni Da Cao,Jin Kun Yang,Jian Zheng,Yin Gu,Ying Ying Han,Ying Jie Zhu,Jin Zu Yang,Feng Gao,Qiang Wang.Survival Benefit of Traditional Chinese Herbal Medicine (a Herbal Formula for Invigorating Spleen) for Patients With Advanced Gastric Cancer[J]. Integrative Cancer Therapies . 2013 (5)
  • 3Gowrikumar Saiprasad,Palanivel Chitra,Ramar Manikandan,Ganapasam Sudhandiran.Hesperidin alleviates oxidative stress and downregulates the expressions of proliferative and inflammatory markers in azoxymethane-induced experimental colon carcinogenesis in mice[J]. Inflammation Research . 2013 (4)
  • 4ROBERT J. CERSOSIMO.Management of advanced colorectal cancer, part 2[J]. American Journal of Health-System Pharmacy . 2013 (6)
  • 5Rebecca Siegel,Deepa Naishadham,Ahmedin Jemal.Cancer statistics, 2013[J]. CA: A Cancer Journal for Clinicians . 2013 (1)
  • 6Asghar Ghorbani,Maryam Nazari,Mahmood Jeddi-Tehrani,Hamid Zand.The citrus flavonoid hesperidin induces p53 and inhibits NF-κB activation in order to trigger apoptosis in NALM-6 cells: involvement of PPARγ-dependent mechanism[J]. European Journal of Nutrition . 2012 (1)
  • 7Soichi Iwai,Atsuko Yonekawa,Chie Harada,Masakazu Hamada,Wataru Katagiri,Mituhiro Nakazawa,Yoshiaki Yura.Involvement of the Wnt-β-catenin pathway in invasion and migration oforal squamous carcinoma cells[J]. International Journal of Oncology . 2010 (5)
  • 8Y. J. Fang,Z. H. Lu,G. Q. Wang,Z. Z. Pan,Z. W. Zhou,J. P. Yun,M. F. Zhang,D. S. Wan.Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer[J]. International Journal of Colorectal Disease . 2009 (8)
  • 9Sharad Sharma,Cemalettin Camci,Nicolas Jabbour.Management of hepatic metastasis from colorectal cancers: an update[J]. Journal of Hepato-Biliary-Pancreatic Surgery . 2008 (6)
  • 10Towards a pan-European consensus on the treatment of patients with colorectal liver metastases[J]. European Journal of Cancer . 2006 (14)

共引文献126

同被引文献35

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部